AL 704

Drug Profile

AL 704

Alternative Names: AL-704; ALS 022704; JNJ 54257099

Latest Information Update: 19 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medivir AB
  • Developer Janssen Infectious Diseases BVBA
  • Class Antivirals; Nucleosides
  • Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hepatitis C

Most Recent Events

  • 21 Dec 2015 Discontinued - Phase-I for Hepatitis C in France (PO) (NCT02510248)
  • 21 Dec 2015 Alios Biopharma completes a phase I trial in Hepatitis C in France
  • 01 Jul 2015 Phase-I clinical trials in Hepatitis C in France (PO) (NCT02510248)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top